Formycon H1 FY26 EBITDA loss narrows to EUR 3.4 million; revenue more than doubled to EUR 25.8 million

Reuters2026/08/12 04:30

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Formycon lifted H1 2026 revenue to EUR 25.8 million from EUR 9 million a year earlier.
EBITDA loss narrowed to EUR 3.4 million from EUR 17.9 million, on higher revenue and lower R&D expenses.
Adjusted EBITDA loss widened to EUR 6.9 million from EUR 19.2 million, reflecting EUR 3.5 million in losses from Bioeq.
Working capital fell to EUR 51.2 million at June 30, 2026 from EUR 70.1 million at Dec. 31, 2025.
Guidance reaffirmed for 2026 revenue of EUR 60 million-EUR 70 million, EBITDA of EUR 0 million-EUR 10 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Formycon AG published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2381014_en) on August 12, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Formycon H1 FY26 EBITDA loss narrows to EUR 3.4 million; revenue more than doubled to EUR 25.8 million

You may also like

Crypto prices